Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
1999 5
2000 4
2001 3
2002 4
2003 4
2004 5
2005 9
2006 7
2007 9
2008 10
2009 14
2010 13
2011 4
2012 8
2013 9
2014 25
2015 13
2016 10
2017 10
2018 11
2019 4
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Results by year
Filters applied: . Clear all
Page 1
Gut Microbiota Linked to Sexual Preference and HIV Infection.
Noguera-Julian M, Rocafort M, Guillén Y, Rivera J, Casadellà M, Nowak P, Hildebrand F, Zeller G, Parera M, Bellido R, Rodríguez C, Carrillo J, Mothe B, Coll J, Bravo I, Estany C, Herrero C, Saz J, Sirera G, Torrela A, Navarro J, Crespo M, Brander C, Negredo E, Blanco J, Guarner F, Calle ML, Bork P, Sönnerborg A, Clotet B, Paredes R. Noguera-Julian M, et al. Among authors: negredo e. EBioMedicine. 2016 Jan 28;5:135-46. doi: 10.1016/j.ebiom.2016.01.032. eCollection 2016 Mar. EBioMedicine. 2016. PMID: 27077120 Free PMC article.
A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
Eron JJ, Orkin C, Gallant J, Molina JM, Negredo E, Antinori A, Mills A, Reynes J, Van Landuyt E, Lathouwers E, Hufkens V, Jezorwski J, Vanveggel S, Opsomer M; AMBER study group. Eron JJ, et al. Among authors: negredo e. AIDS. 2018 Jul 17;32(11):1431-1442. doi: 10.1097/QAD.0000000000001817. AIDS. 2018. PMID: 29683855 Free PMC article. Clinical Trial.
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.
Gupta SK, Post FA, Arribas JR, Eron JJ Jr, Wohl DA, Clarke AE, Sax PE, Stellbrink HJ, Esser S, Pozniak AL, Podzamczer D, Waters L, Orkin C, Rockstroh JK, Mudrikova T, Negredo E, Elion RA, Guo S, Zhong L, Carter C, Martin H, Brainard D, SenGupta D, Das M. Gupta SK, et al. Among authors: negredo e. AIDS. 2019 Jul 15;33(9):1455-1465. doi: 10.1097/QAD.0000000000002223. AIDS. 2019. PMID: 30932951 Free PMC article.
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.
Orkin C, Molina JM, Negredo E, Arribas JR, Gathe J, Eron JJ, Van Landuyt E, Lathouwers E, Hufkens V, Petrovic R, Vanveggel S, Opsomer M; EMERALD study group. Orkin C, et al. Among authors: negredo e. Lancet HIV. 2018 Jan;5(1):e23-e34. doi: 10.1016/S2352-3018(17)30179-0. Epub 2017 Oct 6. Lancet HIV. 2018. PMID: 28993180 Clinical Trial.
High Prevalence of Sarcopenia in HIV-Infected Individuals.
Echeverría P, Bonjoch A, Puig J, Estany C, Ornelas A, Clotet B, Negredo E. Echeverría P, et al. Among authors: negredo e. Biomed Res Int. 2018 Jul 12;2018:5074923. doi: 10.1155/2018/5074923. eCollection 2018. Biomed Res Int. 2018. PMID: 30112397 Free PMC article.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Guillén Y, et al. Among authors: negredo e. Mucosal Immunol. 2019 Jan;12(1):232-246. doi: 10.1038/s41385-018-0083-7. Epub 2018 Aug 31. Mucosal Immunol. 2019. PMID: 30171206 Free article.
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
Blanco JL, Rojas J, Paredes R, Negredo E, Mallolas J, Casadella M, Clotet B, Gatell JM, de Lazzari E, Martinez E; DOLAM Study Team. Blanco JL, et al. Among authors: negredo e. J Antimicrob Chemother. 2018 Jul 1;73(7):1965-1971. doi: 10.1093/jac/dky093. J Antimicrob Chemother. 2018. PMID: 29608685 Clinical Trial.
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
Pérez-Molina JA, Martínez E, Blasco AJ, Arribas JR, Domingo P, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Mariño A, Miró JM, Moreno S, Negredo E, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, von Wichmann MA, Gatell JM. Pérez-Molina JA, et al. Among authors: negredo e. Enferm Infecc Microbiol Clin. 2019 Mar;37(3):151-159. doi: 10.1016/j.eimc.2018.04.010. Epub 2018 Jun 6. Enferm Infecc Microbiol Clin. 2019. PMID: 29884455 English, Spanish.
Memory B cell dysregulation in HIV-1-infected individuals.
Carrillo J, Negredo E, Puig J, Molinos-Albert LM, Rodríguez de la Concepción ML, Curriu M, Massanella M, Navarro J, Crespo M, Viñets E, Millá F, Clotet B, Blanco J. Carrillo J, et al. Among authors: negredo e. AIDS. 2018 Jan 14;32(2):149-160. doi: 10.1097/QAD.0000000000001686. AIDS. 2018. PMID: 29112067
Executive summary of the consensus document on osteoporosis in HIV-infected individuals.
Negredo E, Domingo P, Gutiérrez F, Galindo MJ, Knobel H, Lozano F, Martínez E, Masiá M, Polo R, Estrada V. Negredo E, et al. Enferm Infecc Microbiol Clin. 2018 May;36(5):312-314. doi: 10.1016/j.eimc.2017.03.010. Epub 2017 May 31. Enferm Infecc Microbiol Clin. 2018. PMID: 28579014 English, Spanish.
177 results
Jump to page
Feedback